Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5017)
All Articles published online
|
Feb 21, 2013 (publication date) through Jun 12, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Frei P, Biedermann L, Nielsen OH, Rogler G. Use of thiopurines in inflammatory bowel disease. World J Gastroenterol 2013; 19(7): 1040-1048 [PMID: 23467510 DOI: 10.3748/wjg.v19.i7.1040] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i7/1040.htm |
| Number | Citing Articles |
| 1 |
Sruthi Vijaya Retnakumar, Sylviane Muller. Pharmacological Autophagy Regulators as Therapeutic Agents for Inflammatory Bowel Diseases. Trends in Molecular Medicine 2019; 25(6): 516 doi: 10.1016/j.molmed.2019.03.002
|
| 2 |
Joana Couceiro, Irina Matos, José João Mendes, Pedro V. Baptista, Alexandra R. Fernandes, Alexandre Quintas. Inflammatory factors, genetic variants, and predisposition for preterm birth. Clinical Genetics 2021; 100(4): 357 doi: 10.1111/cge.14001
|
| 3 |
Marius Vögelin, Luc Biedermann, Pascal Frei, Stephan R. Vavricka, Sylvie Scharl, Jonas Zeitz, Michael C. Sulz, Michael Fried, Gerhard Rogler, Michael Scharl, John Green. The Impact of Azathioprine-Associated Lymphopenia on the Onset of Opportunistic Infections in Patients with Inflammatory Bowel Disease. PLOS ONE 2016; 11(5): e0155218 doi: 10.1371/journal.pone.0155218
|
| 4 |
Firas Abu Hanna, Ohad Atia, Anat Yerushalmy Feler, Dror Shouval, Batia Weiss, Hadeel Mresat, Ramit Magen-Rimon, Eyal Zifman, Dan Turner, Firas Rinawi. Thiopurines Maintenance Therapy in Children With Ulcerative Colitis: A Multicenter Retrospective Study. Journal of Pediatric Gastroenterology & Nutrition 2023; 77(4): 505 doi: 10.1097/MPG.0000000000003899
|
| 5 |
Jintong Niu, Yang Guo, Guoxin Jing, Hong Wang, Li Yang, Youyuan Li, Yi Gao, Huichao Wang, Ang Li, Xiaorong Xu, Yechang Qian, Jian Fei, Shilong Wang. Anion‐Dependent Layered Double Hydroxide Nanoparticles Regulate Differentiation of CD206+ CX3CR1+ Macrophages by Inhibiting the IL‐17 Signaling Pathway Contributing to Inflammatory Bowel Disease. Advanced Functional Materials 2024; 34(14) doi: 10.1002/adfm.202305042
|
| 6 |
Marçal Pastor-Anglada, Sandra Pérez-Torras. Nucleoside transporter proteins as biomarkers of drug responsiveness and drug targets. Frontiers in Pharmacology 2015; 6 doi: 10.3389/fphar.2015.00013
|
| 7 |
Gabriella Bröms, Fredrik Granath, Olof Stephansson, Helle Kieler. Preterm birth in women with inflammatory bowel disease – the association with disease activity and drug treatment. Scandinavian Journal of Gastroenterology 2016; 51(12): 1462 doi: 10.1080/00365521.2016.1208269
|
| 8 |
Faith D. Ihekweazu, Richard Kellermayer. Allopurinol. Journal of Pediatric Gastroenterology and Nutrition 2014; 59(1): 22 doi: 10.1097/MPG.0000000000000344
|
| 9 |
A. J. Czaja. Review article: permanent drug withdrawal is desirable and achievable for autoimmune hepatitis. Alimentary Pharmacology & Therapeutics 2014; 39(10): 1043 doi: 10.1111/apt.12701
|
| 10 |
Bincy P. Abraham, Tasneem Ahmed, Tauseef Ali. Gastrointestinal Pharmacology. Handbook of Experimental Pharmacology 2017; 239: 115 doi: 10.1007/164_2016_122
|
| 11 |
Dragan Primorac, Lidija Bach-Rojecky. Pharmacogenomics in Clinical Practice. 2023; : 239 doi: 10.1007/978-3-031-45903-0_12
|
| 12 |
Ahmed B. Bayoumy, Melek Simsek, Margien L. Seinen, Chris J.J. Mulder, Azhar Ansari, Godefridus J. Peters, Nanne K. De Boer. The continuous rediscovery and the benefit–risk ratio of thioguanine, a comprehensive review. Expert Opinion on Drug Metabolism & Toxicology 2020; : 1 doi: 10.1080/17425255.2020.1719996
|
| 13 |
Lauranne A.A.P. Derikx, Levinus A. Dieleman, Frank Hoentjen. Probiotics and prebiotics in ulcerative colitis. Best Practice & Research Clinical Gastroenterology 2016; 30(1): 55 doi: 10.1016/j.bpg.2016.02.005
|
| 14 |
Rangnath Mishra, Punita Dhawan, Anand S Srivastava, Amar B Singh. Inflammatory bowel disease: Therapeutic limitations and prospective of the stem cell therapy. World Journal of Stem Cells 2020; 12(10): 1050-1066 doi: 10.4252/wjsc.v12.i10.1050
|
| 15 |
Mattheus CB Wielenga, Jooske F van Lidth de Jeude, Sanne L Rosekrans, Alon D Levin, Monique Schukking, Geert RAM D’Haens, Jarom Heijmans, Marnix Jansen, Vanesa Muncan, Gijs R van den Brink. Azathioprine does not reduce adenoma formation in a mouse model of sporadic intestinal tumorigenesis. World Journal of Gastroenterology 2014; 20(44): 16683-16689 doi: 10.3748/wjg.v20.i44.16683
|
| 16 |
Ole Haagen Nielsen, Cynthia Maxwell, Jakob Hendel. IBD medications during pregnancy and lactation. Nature Reviews Gastroenterology & Hepatology 2014; 11(2): 116 doi: 10.1038/nrgastro.2013.135
|
| 17 |
Ji Young Chang, Jae Hee Cheon. Thiopurine Therapy in Patients With Inflammatory Bowel Disease: A Focus on Metabolism and Pharmacogenetics. Digestive Diseases and Sciences 2019; 64(9): 2395 doi: 10.1007/s10620-019-05720-5
|
| 18 |
Matti Waterman, Daniel Kurnik, Yehuda Chowers. Is Super-Selective Superior?. Journal of Crohn's and Colitis 2016; 10(10): 1129 doi: 10.1093/ecco-jcc/jjw128
|
| 19 |
Martin Kummen, Erik Schrumpf, Kirsten Muri Boberg. Liver abnormalities in bowel diseases. Best Practice & Research Clinical Gastroenterology 2013; 27(4): 531 doi: 10.1016/j.bpg.2013.06.013
|
| 20 |
M. Teresa Pacheco, Teresa Vezza, Patricia Diez-Echave, Pilar Utrilla, Mar Villamiel, F. Javier Moreno. Anti-inflammatory bowel effect of industrial orange by-products in DSS-treated mice. Food & Function 2018; 9(9): 4888 doi: 10.1039/C8FO01060A
|
| 21 |
Luc Biedermann, Gerhard Rogler. Chronisch-entzündliche Darmerkrankungen. 2020; : 285 doi: 10.1007/978-3-662-59104-8_20
|
| 22 |
Ana Lúcia Sousa, Paulo Caldeira, Marta Eusébio, Alda Martins, Teresa Belo, Horácio Guerreiro. Azatioprina na doença inflamatória intestinal: fatores preditivos da resposta sustentada a longo prazo. GE Jornal Português de Gastrenterologia 2014; 21(4): 147 doi: 10.1016/j.jpg.2014.05.002
|
| 23 |
Gerassimos J. Mantzaris. Thiopurines and Methotrexate Use in IBD Patients in a Biologic Era. Current Treatment Options in Gastroenterology 2017; 15(1): 84 doi: 10.1007/s11938-017-0128-0
|
| 24 |
Berrie Meijer, Chris JJ Mulder, Adriaan A van Bodegraven, Nanne K H de Boer. How I treat my inflammatory bowel disease-patients with thiopurines?. World Journal of Gastrointestinal Pharmacology and Therapeutics 2016; 7(4): 524-530 doi: 10.4292/wjgpt.v7.i4.524
|
| 25 |
Sayeed Ur Rehman, Haseeb Zubair, Tarique Sarwar, Mohammed Amir Husain, Hassan Mubarak Ishqi, Shamshun Nehar, Mohammad Tabish. Redox cycling of Cu(II) by 6-mercaptopurine leads to ROS generation and DNA breakage: possible mechanism of anticancer activity. Tumor Biology 2015; 36(2): 1237 doi: 10.1007/s13277-014-2743-x
|
| 26 |
Polina Zalizko, Juris Stefanovics, Jelizaveta Sokolovska, Natalia Paramonova, Evija Klavina, Renars Erts, Vita Rovite, Janis Klovins, Aldis Pukitis. Thiopurine S-methyltransferase genetic polymorphisms in adult patients with inflammatory bowel diseases in the Latvian population. Therapeutic Advances in Gastroenterology 2020; 13: 175628482093742 doi: 10.1177/1756284820937426
|
| 27 |
Karen van Hoeve, Séverine Vermeire. Thiopurines in Pediatric Inflammatory Bowel Disease: Current and Future Place. Pediatric Drugs 2020; 22(5): 449 doi: 10.1007/s40272-020-00411-5
|